Pharmacological strategies have been developed for patients with major depressive disorder who fail to respond to standard drug treatment. The current clinical approach primarily relies on counting episodes that fulfill specific criteria and regards non-pharmacological strategies as of marginal value, despite their recognized importance in treating depression. Most attention is devoted to treatment-resistant patients' characteristics rather than to the process related to therapeutic management. However, how the patient experiences the treatment process, his/her interaction with the physician/therapist and significant others, and the patient's role in treatment plan (self-management) are all essential therapeutic components. A broader evaluation of factors related to the patient (e.g., illness denial, psychological reactance, demoralization), the therapy (e.g., clinician's attitude, behavioral toxicity of antidepressants), the environment (e.g., allostatic load/overload and health-damaging behaviors), and morbidity (e.g., medical and psychiatric comorbidity) is warranted. Assessment based on clinimetric methods (i.e., staging, macro-analysis) and clinical judgment allow a differential diagnosis of phenomena such as non-response, pseudo-resistance, treatment resistance, loss of clinical effect during maintenance antidepressant treatment, failure to achieve remission after a psychotherapy trial, partially remitted depression (i.e., presence of residual symptoms). Choice of the psychotherapeutic approach for treatment-resistant depression (TRD), particularly cognitive-behavioral therapy, mindfulness-based cognitive therapy and interpersonal psychotherapy, should follow the indications derived from clinical assessment. Treatment of TRD can thus be conceptualized as an integrated therapeutic approach to different components encompassing symptoms, psychosocial factors, lifestyle and psychological well-being.

Guidi, J., Fava, G.A. (2025). The clinical inadequacy of the concept of treatment-resistant depression: Innovative strategies in assessment and psychotherapeutic management. CLINICAL PSYCHOLOGY REVIEW, 120, 1-10 [10.1016/j.cpr.2025.102616].

The clinical inadequacy of the concept of treatment-resistant depression: Innovative strategies in assessment and psychotherapeutic management

Guidi, Jenny
Primo
;
Fava, Giovanni A
2025

Abstract

Pharmacological strategies have been developed for patients with major depressive disorder who fail to respond to standard drug treatment. The current clinical approach primarily relies on counting episodes that fulfill specific criteria and regards non-pharmacological strategies as of marginal value, despite their recognized importance in treating depression. Most attention is devoted to treatment-resistant patients' characteristics rather than to the process related to therapeutic management. However, how the patient experiences the treatment process, his/her interaction with the physician/therapist and significant others, and the patient's role in treatment plan (self-management) are all essential therapeutic components. A broader evaluation of factors related to the patient (e.g., illness denial, psychological reactance, demoralization), the therapy (e.g., clinician's attitude, behavioral toxicity of antidepressants), the environment (e.g., allostatic load/overload and health-damaging behaviors), and morbidity (e.g., medical and psychiatric comorbidity) is warranted. Assessment based on clinimetric methods (i.e., staging, macro-analysis) and clinical judgment allow a differential diagnosis of phenomena such as non-response, pseudo-resistance, treatment resistance, loss of clinical effect during maintenance antidepressant treatment, failure to achieve remission after a psychotherapy trial, partially remitted depression (i.e., presence of residual symptoms). Choice of the psychotherapeutic approach for treatment-resistant depression (TRD), particularly cognitive-behavioral therapy, mindfulness-based cognitive therapy and interpersonal psychotherapy, should follow the indications derived from clinical assessment. Treatment of TRD can thus be conceptualized as an integrated therapeutic approach to different components encompassing symptoms, psychosocial factors, lifestyle and psychological well-being.
2025
Guidi, J., Fava, G.A. (2025). The clinical inadequacy of the concept of treatment-resistant depression: Innovative strategies in assessment and psychotherapeutic management. CLINICAL PSYCHOLOGY REVIEW, 120, 1-10 [10.1016/j.cpr.2025.102616].
Guidi, Jenny; Fava, Giovanni A
File in questo prodotto:
File Dimensione Formato  
The clinical inadequacy of the concept of treatment-resistant depression_Innovative strategies in assessment and psychotherapeutic management.pdf

accesso aperto

Tipo: Versione (PDF) editoriale / Version Of Record
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 2.19 MB
Formato Adobe PDF
2.19 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/1042813
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact